CJC-1295 + Ipamorelin is a USA-manufactured dual-peptide GH axis research blend combining CJC-1295 No DAC (ModGRF 1-29) a synthetic GHRH analogue that activates the GHRH receptor on anterior pituitary somatotrophs via Gs-cAMP signaling and Ipamorelin, a selective GH secretagogue that activates the ghrelin receptor (GHS-R1a) via the distinct Gq/11 intracellular pathway, providing simultaneous dual-receptor GH axis stimulation in a single research preparation
Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention
Either way, the supervised clinical model itself does not change
The metabolites of chronic overnutrition, such as hyperglycaemia and non-esterified FAs (NEFAs), disrupt with the activation of the INSR and its downstream IRS-1/PI3K/Akt2 pathway
Still, neither peptide is approved for cosmetic use, and neither is considered particularly safe when acquired outside of a medical setting
Researchers are exploring potential links between GLP-1 drugs and headaches